Clinical Trials Logo
  1. Home
  2. Male Hypogonadism
  3. NCT01228071

Time to Eugonadal Range, Time to Steady State and Drying Time

Male Hypogonadism Clinical Trial

Official title:
Assessment of Time to Eugonadal Testosterone Range After Initial Fortesta (Testosterone) Gel 2% Application, Time to Steady State After Initiation of Fortesta, And Gel Drying Time After Fortesta Application

Clinical Trial Summary

This is a multicenter, open-label, single arm trial to evaluate the time to eugonadal testosterone range after initial testosterone gel 2% application, time to steady state after after initiation of testosterone gel 2%, and drying time after application of testosterone gel 2%.

Clinical Trial Description

Assessment of Time to Eugonadal Testosterone Range After Initial Fortesta (Testosterone) Gel 2% Application, Time to Steady State After Initiation of Fortesta, And Gel Drying Time After Fortesta Application ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01228071
Study type Interventional
Source Endo Pharmaceuticals
Contact
Status Completed
Phase Phase 3
Start date November 2010
Completion date May 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT01446042 - Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism Phase 3
Completed NCT02966652 - Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism Phase 1
Withdrawn NCT02715713 - Autonomic Manifestations of Testosterone Deficiency in Men N/A
Completed NCT00858650 - Registry of Hypogonadism in Men N/A
Recruiting NCT05541172 - Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism
Not yet recruiting NCT04704141 - Relationship of the Microenvironment and Male Fertility
Completed NCT01403116 - Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Phase 3
Completed NCT00924612 - Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation Phase 2
Completed NCT00911586 - Pharmacokinetic Study to Determine Time to Steady-state Phase 2
Completed NCT01765179 - Safety and Efficacy Trial of Testosterone Undecanoate Phase 3
Completed NCT00475501 - 5-Alpha Reductase and Anabolic Effects of Testosterone Phase 2
Completed NCT04708249 - D-chiroinositol Administration in Hypogonadal Males N/A
Completed NCT02081300 - Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism Phase 3
Active, not recruiting NCT03721497 - Testosterone in Bariatric Patients Phase 4
Completed NCT01699178 - Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men Phase 3